Iodide

Iodide

SCHEMBL30187207

[I-].[I-].c1ccc2c(c1)ccc[n+]2CCCCCCCCCCCCCCCCCCCC[n+]1cccc2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 14/20 0.96
BCHE P06276 14/20 0.96

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL2332855 1.00 BCHE (0.96) BCHEACHE
Iodide SCHEMBL28459531 1.00 BCHE (0.96) BCHEACHE
SCHEMBL3606932 0.98 BCHE (1.00) BCHEACHE
SCHEMBL3603725 0.98 BCHE (1.00) BCHEACHE
SCHEMBL14951076 0.98 BCHE (1.00) BCHEACHE
SCHEMBL4887020 0.98 BCHE (1.00) BCHEACHE
SCHEMBL3588425 0.98 BCHE (1.00) BCHEACHE
SCHEMBL3604422 0.98 BCHE (1.00) BCHEACHE
SCHEMBL3596114 0.98 BCHE (1.00) BCHEACHE
Bromide SCHEMBL4891809 0.96 BCHE (1.00) BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240251664-A1 LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-25 US claimed
EP-4748447-A2 INFLUENZA VIRUS VACCINES AND USES THEREOF Icahn School of Medicine at Mount Sinai (US) 2026-05-27 EP disclosed
US-12573473-B2 Ultra-sensitive detection of circulating tumor DNA through genome-wide integration CORNELL UNIVERSITY (US) 2026-03-10 US disclosed
US-20260048114-A1 INFLUENZA VIRUS VACCINATION REGIMENS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2026-02-19 US disclosed
EP-4241785-B1 INFLUENZA VIRUS VACCINES AND USES THEREOF ICAHN SCHOOL MED MOUNT SINAI (US) 2026-01-28 EP disclosed
US-20260001918-A1 INFLUENZA VIRUS VACCINES AND USES THEREOF ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2026-01-01 US disclosed
CN-112601826-B Ultrasensitive detection of circulating tumor DNA by whole genome integration 康奈尔大学 2025-03-11 CN disclosed
US-20240251664-A1 LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-25 US disclosed
EP-4241785-A2 INFLUENZA VIRUS VACCINES AND USES THEREOF Icahn School of Medicine at Mount Sinai (US) 2023-09-13 EP disclosed
EP-2758075-B1 INFLUENZA VIRUS VACCINES AND USES THEREOF ICAHN SCHOOL MED MOUNT SINAI (US) 2023-05-03 EP disclosed
CN-218173406-U Asphalt storage tank air release valve 山东坤达公路材料有限公司 2022-12-30 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260048114-A1 INFLUENZA VIRUS VACCINATION REGIMENS H1-3, CD81, FUT8 ACHE 2725/4885BCHE 2357/4885
US-12573473-B2 Ultra-sensitive detection of circulating tumor DNA through genome-wide integration BRCA1, TSG101, UNG ACHE 4885/4885BCHE 4874/4885
US-20240251664-A1 LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME NES, NFE2L2, NUCB2 ACHE 185/4885BCHE 648/4885
US-20260001918-A1 INFLUENZA VIRUS VACCINES AND USES THEREOF CD44, SIGLEC7, SIGLEC9 ACHE 2838/4885BCHE 2721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.